Mercer Global Advisors
IONS icon

Mercer Global Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Mercer Global Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Buy
6,918
+622
+10% +$46.8K ﹤0.01% 2216
2026
Q1 		$473K Buy
6,296
+742
+13% +$58.6K ﹤0.01% 2032
2025
Q4 		$439K Buy
5,554
+1,807
+48% +$136K ﹤0.01% 1955
2025
Q3 		$245K Buy
+3,747
New +$183K ﹤0.01% 2238
2024
Q1 		– Sell
-4,676
Closed -$237K – 2094
2023
Q4 		$237K Sell
4,676
-420
-8% -$20.1K ﹤0.01% 1745
2023
Q3 		$231K Sell
5,096
-267
-5% -$11K ﹤0.01% 1692
2023
Q2 		$220K Buy
+5,363
New +$206K ﹤0.01% 1693
2022
Q3 		– Sell
-5,396
Closed -$200K – 1871
2022
Q2 		$200K Buy
+5,396
New +$203K ﹤0.01% 1636
2020
Q1 		– Sell
-3,449
Closed -$208K – 1174
2019
Q4 		$208K Sell
3,449
-893
-21% -$53.2K ﹤0.01% 1070
2019
Q3 		$260K Sell
4,342
-446
-9% -$29.1K 0.01% 938
2019
Q2 		$308K Buy
4,788
+1,749
+58% +$124K 0.01% 866
2019
Q1 		$247K Buy
+3,039
New +$196K 0.01% 906

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mercer Global Advisors's IONS Position: Q2 2026 in Review

Mercer Global Advisors increased its Ionis Pharmaceuticals (IONS) stake by 9.9% in Q2 2026, buying an estimated $46.8K and bringing the position to 6,918 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Mercer Global Advisors first reported a position in IONS in Q1 2019 and has held it in 12 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Mercer Global Advisors held 6,918 shares of Ionis Pharmaceuticals worth $548K as of Q2 2026.
  • Mercer Global Advisors bought 622 Ionis Pharmaceuticals shares in Q2 2026, an estimated $46.8K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2216 holding.
  • Mercer Global Advisors first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 12 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.